This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Dec 1;5(12):e2247054.

doi: 10.1001/jamanetworkopen.2022.47054.

Taking Stock After Another Negative Erythropoietin Neuroprotection Trial

Thomas R Wood¹, Sandra E Juul¹

Affiliations

PMID: 36459142
DOI: 10.1001/jamanetworkopen.2022.47054

Free article

Comment

Taking Stock After Another Negative Erythropoietin Neuroprotection Trial

Thomas R Wood et al. JAMA Netw Open. 2022.

Free article

. 2022 Dec 1;5(12):e2247054.

doi: 10.1001/jamanetworkopen.2022.47054.

Authors

Thomas R Wood¹, Sandra E Juul¹

Affiliation

¹ Division of Neonatology, Pediatrics, University of Washington, Seattle.

PMID: 36459142
DOI: 10.1001/jamanetworkopen.2022.47054

No abstract available

PubMed Disclaimer

Comment on

Safety and Short-term Outcomes of High-Dose Erythropoietin in Preterm Infants With Intraventricular Hemorrhage: The EpoRepair Randomized Clinical Trial.
Wellmann S, Hagmann CF, von Felten S, Held L, Klebermass-Schrehof K, Truttmann AC, Knöpfli C, Fauchère JC, Bührer C, Bucher HU, Rüegger CM; Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair) Investigators. Wellmann S, et al. JAMA Netw Open. 2022 Dec 1;5(12):e2244744. doi: 10.1001/jamanetworkopen.2022.44744. JAMA Netw Open. 2022. PMID: 36459138 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems